Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
04/2000
04/13/2000WO2000020637A1 Method for identifying compounds affecting rna/rna binding protein interactions
04/13/2000WO2000020636A1 Methods of identifying inverse agonists of the serotonin 2a receptor
04/13/2000WO2000020635A1 ANTISENSE MODULATION OF INTEGRIN α4 EXPRESSION
04/13/2000WO2000020634A1 Methods for treating or identifying a subject at risk for a neurological disease by determining the presence of a variant gpiiia and/or variant gpiib allele
04/13/2000WO2000020633A1 Detection of nucleic acid polymorphism
04/13/2000WO2000020632A1 Susceptibility locus for osteoarthritis
04/13/2000WO2000020631A1 Susceptibility locus for osteoarthritis
04/13/2000WO2000020630A1 Oligonucleotide primers that destabilize non-specific duplex formation and uses thereof
04/13/2000WO2000020629A2 Quantitation of rna
04/13/2000WO2000020628A1 Multi-loci genomic analysis by a method of improved cycle sequencing
04/13/2000WO2000020627A1 Use of ynes, essential bacterial genes and polypeptides
04/13/2000WO2000020626A1 Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator
04/13/2000WO2000020624A1 Use of socs-2 or cis to screen for compounds enhancing growth hormone effect
04/13/2000WO2000020621A1 Extracellular novel rage binding protein (en-rage) and uses thereof
04/13/2000WO2000020605A1 Sulfotransferase sequence variants
04/13/2000WO2000020590A2 G-protein coupled receptor proteins
04/13/2000WO2000020587A2 Cancer associated antigens and uses therefor
04/13/2000WO2000020581A1 Mage-a3 peptides presented by hla class ii molecules
04/13/2000WO2000020575A1 Pollinosis-associated gene
04/13/2000WO2000020574A2 Fusions of scaffold proteins with random peptide libraries
04/13/2000WO2000020568A1 Sugar transferases of pathogens
04/13/2000WO2000020562A1 A novel lymphocyte population expressing intracellular mo2
04/13/2000WO2000020558A1 METHOD FOR PREPARING HIGH PERFORMANCE RecA-LIKE RECOMBINASE/SINGLE-STRANDED NUCLEIC ACID PROBE COMPLEX AND UTILIZATION THEREOF
04/13/2000WO2000020556A2 Zinc finger-reactive antimicrobial compounds
04/13/2000WO2000020554A1 Microfabricated cell injector
04/13/2000WO2000020458A1 Methods for determining whether a compound is capable of inhibiting the interaction of a peptide with rage
04/13/2000WO2000020457A1 Peptides related to an igf-ii-r epitope, polynucleotides encoding the peptides, and their use in immunomodulation
04/13/2000WO2000020450A2 Calcium channel alpha-2/delta gene
04/13/2000WO2000020448A2 Nlk1 -interacting proteins
04/13/2000WO2000020447A2 Polynucleotides coding for secreted polypeptides, some having similarity to syncollin or claudin or cytokine, their therapeutic uses
04/13/2000WO2000020446A2 Bax-mediated apoptosis modulating reagents and methods
04/13/2000WO2000020445A2 Tumor antigens and ctl clones isolated by a novel procedure
04/13/2000WO2000020444A1 Novel peptides
04/13/2000WO2000020443A1 Novel peptides
04/13/2000WO2000020438A1 G protein-coupled receptor resembling the thrombin receptor
04/13/2000WO2000020436A1 An isolated polynucleotide associated with type ii diabetes mellitus and methods of use thereof
04/13/2000WO2000020435A1 ANTISENSE MODULATION OF EXPRESSION OF TUMOR NECROSIS FACTOR RECEPTOR-ASSOCIATED FACTORS (TRAFs)
04/13/2000WO2000020434A1 Cadherin-like asymmetry protein-1, and methods for its use
04/13/2000WO2000020433A1 Cytotoxic agents for the selective killing of lymphoma and leukemia cells and methods of use thereof
04/13/2000WO2000020044A1 A novel method of diagnosing, monitoring, staging, imaging and treating gynecologic cancers
04/13/2000WO2000020043A1 A novel method of diagnosing, monitoring, staging and treating gynecological and prostatic cancers
04/13/2000WO2000020037A1 A novel component in the hedgehog signalling pathway
04/13/2000WO2000020031A1 Methods for identification, diagnosis, and treatment of breast cancer
04/13/2000WO2000020029A1 Genes differentially expressed in cancer cells to design cancer vaccines
04/13/2000WO2000020020A2 Method for screening for anti-amyloidogenic properties and method for treatment of neurodegenerative disease
04/13/2000WO2000020011A1 Isolated dna encoding human h3 histamine receptor
04/13/2000WO2000019988A1 NOVEL Th2-SPECIFIC MOLECULES AND USES THEREOF
04/13/2000WO2000019883A2 Compositions and methods of disease diagnosis and therapy
04/13/2000WO2000011214B1 Molecular differences between species of the m. tuberculosis complex
04/13/2000WO2000003015A3 Human transport protein homologs
04/13/2000WO2000001415A3 Use of inhibitors of protein kinase c epsilon to treat pain
04/13/2000WO2000000634A3 METHODS OF INHIBITING $i(HELICOBACTER PYLORI)
04/13/2000WO2000000608A3 Immune system molecules
04/13/2000WO1999067428A3 Method for detection of drug-selected mutations in the hiv protease gene
04/13/2000WO1999064576A3 Human genes differentially expressed in colon cancer
04/13/2000WO1999051265A9 Nucleic acid encoding hyaluronan synthase and methods of use
04/13/2000WO1999050454A3 Coding sequence polymorphisms in vascular pathology genes
04/13/2000WO1999045387A3 Electrochemical analyte sensor
04/13/2000DE19846301A1 Optical assay for determining alkaline phosphatase in samples uses specified primary and secondary measurement wavelengths
04/13/2000DE19846300A1 Optical assay for determining alkaline phosphatase in samples uses a specified primary measurement wavelength in combination with a rate blank correction
04/13/2000CA2354544A1 Methods for treating or identifying a subject at risk for a neurological disease by determining the presence of a variant gpiiia and/or variant gpiib allele
04/13/2000CA2349127A1 Molecular diagnostics for galactosemia
04/13/2000CA2347120A1 Nlk1 -interacting proteins
04/13/2000CA2346765A1 Compositions and methods of disease diagnosis and therapy
04/13/2000CA2346496A1 Novel th2-specific molecules and uses thereof
04/13/2000CA2346339A1 Methods for determining whether a compound is capable of inhibiting the interaction of a peptide with rage
04/13/2000CA2346326A1 A novel method of diagnosing, monitoring, staging and treating gynecological and prostatic cancers
04/13/2000CA2346217A1 Extracellular novel rage binding protein (en-rage) and uses thereof
04/13/2000CA2346146A1 Oligonucleotide primers that destabilize non-specific duplex formation and uses thereof
04/13/2000CA2346134A1 G protein-coupled receptor resembling the thrombin receptor
04/13/2000CA2346070A1 Bax-mediated apoptosis modulating reagents and methods
04/13/2000CA2346068A1 A novel lymphocyte population expressing intracellular mo2
04/13/2000CA2346048A1 Methods for identification, diagnosis, and treatment of breast cancer
04/13/2000CA2345881A1 Bone marrow-derived serum proteins
04/13/2000CA2345663A1 Screen for risk for gastric adenocarcinoma
04/13/2000CA2345477A1 Peptides related to an igf-ii-r epitope, polynucleotides encoding the peptides, and their use in immunomodulation
04/13/2000CA2345440A1 Genes differentially expressed in cancer cells to design cancer vaccines
04/13/2000CA2345377A1 Novel secreted proteins and polynucleotides encoding them
04/13/2000CA2345285A1 A novel method of diagnosing, monitoring, staging, imaging and treating gynecologic cancers
04/13/2000CA2345215A1 Fusions of scaffold proteins with random peptide libraries
04/13/2000CA2345212A1 Zinc finger-reactive antimicrobial compounds
04/13/2000CA2345209A1 Antisense modulation of integrin .alpha.4 expression
04/13/2000CA2345045A1 G-protein coupled receptor proteins
04/13/2000CA2345000A1 A novel method of diagnosing, monitoring, staging, imaging and treating gastrointestinal cancers
04/13/2000CA2344995A1 Cancer associated antigens and uses therefor
04/13/2000CA2344973A1 Oxidoreductase molecules
04/13/2000CA2344765A1 Novel peptides
04/13/2000CA2344623A1 Method to determine a predisposition to leptin treatment
04/13/2000CA2344618A1 Method for identifying compounds affecting rna/rna binding protein interactions
04/13/2000CA2344563A1 Methods and compositions for the diagnosis and therapy of prostate cancer
04/13/2000CA2344551A1 P-conotoxin peptide
04/13/2000CA2344468A1 Method for preparing high performance reca-like recombinase/single-stranded nucleic acid probe complex and utilization thereof
04/13/2000CA2344266A1 Cadherin-like asymmetry protein-1, and methods for its use
04/13/2000CA2343651A1 Use of socs-2 or cis to screen for compounds enhancing growth hormone effect
04/13/2000CA2342606A1 Thromboplastin reagents and methods for preparing and using such reagents
04/13/2000CA2341351A1 Alpha-2/delta gene
04/12/2000EP0992589A2 Glucose sensor
04/12/2000EP0992585A2 Human calcium channel compositions and methods
04/12/2000EP0992584A2 Purified mammalian FLT3 ligands and agonists and antagonists thereof
04/12/2000EP0992511A1 Methods and compositions for determining the sequence of nucleic acid molecules
1 ... 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 2569 2570 2571 2572 2573 2574 2575 2576 2577 2578 ... 3003